• Visit our Literature Section for a link to an interesting and important new Research Article on Cancer Risk in adults with Type 1 Gaucher Disease.

  • We are attending the WORLDSymposium 2023 Annual Meeting in Orlando, Florida #WORLDSymposia. Connect with us there.

  • Contact us via LinkedIn or by email.


What is Gaucher Disease?

GD is a genetic disorder caused by a recessive mutation in the GBA gene located on chromosome 1. It is a rare disorder and patients with GD may present with a broad range of signs and symptoms. These may include enlarged spleen and liver, liver malfunction, skeletal disorders or bone lesions that may be painful, severe neurological complications, swelling of lymph nodes, anemia and low blood platelet count. Persons seriously affected may also be more susceptible to infection.

Learn More
Person holding test tubes

Who is the platform for?

This platform will share information to support the care of patients with Gaucher Disease (GD).

It has been developed by the European GD Network, an EHA SWG GD Task Force, as a trusted online resource for everyone involved in the care of Gaucher Disease patients.

The content of the Platform is available for:

Hematologists, clinical nurse specialists and other healthcare professionals (HCPs).

GD patients, their family, friends, carers (care-givers) and GD patient advocacy groups.


The Key Facts

Learn More

International Advisory Committee

Sam Salek (Chair)
Marc Berger
Tim Cox
Elena Lukina
Sigurd Orstavik
Kate Theochari

Argiris Symeonidis (Co-Chair)
Tanya Collins-Histed
Christina Fraga
Maciej Machaczka
Hanna Rosenbaum
Michael Wajnrach